Drug Release, Susceptibility and Time-Kill Assays to Develop Novel Anti-Infective Drugs
Authors:
- İmRen Esentürk-GüzelIEİmRen Esentürk-Güzel
- Meltem Ezgi DurgunMDMeltem Ezgi Durgun
- Yıldız ÖzsoyYÖYıldız Özsoy
- Sevgi GüngörSGSevgi Güngör
- 6 January 2022
- book chapter
- Published by Elsevier
- p. 640-651
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challengesDrug Delivery and Translational Research, 2013
- In Vitro Pharmacokinetic/Pharmacodynamic Models in Anti-Infective Drug Development: Focus on TBFuture Medicinal Chemistry, 2010
- Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus IDrug Development and Industrial Pharmacy, 2010
- Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary PracticesClinical Infectious Diseases, 2009
- Spending on new drug development1Health Economics, 2009
- Current perspectives in dissolution testing of conventional and novel dosage formsInternational Journal of Pharmaceutics, 2007
- Modelling time–kill studies to discern the pharmacodynamics of meropenemJournal of Antimicrobial Chemotherapy, 2005
- Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteriaDiseases of Aquatic Organisms, 2005
- Antibacterial drug discovery in the 21st centuryClinical Microbiology and Infection, 2004
- The developing biosensor arenaEnzyme and Microbial Technology, 1986